Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,030.50p
   
  • Change Today:
    -47.00p
  • 52 Week High: 1,208.50
  • 52 Week Low: 917.60
  • Currency: UK Pounds
  • Shares Issued: 875.93m
  • Volume: 3,458,286
  • Market Cap: £9,026m
  • RiskGrade: 173
  • Beta: 0.02

Deal with Barclays    Trade now with Barclays Stockbrokers

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.8% 0.0%
Div Cover 2.2 2.6
Op Mrgn 11.3% 17.2%
ROCE 13.3%  
Latest F'cast
P/E 15.8 11.8
PEG 8.7 0.7
Pr/Revenue 2.0 1.4
Pr/Book 2.2  
Latest F'cast
Revenue 4.7% -19.1%
PBT 71.7% 62.6%
EPS 1.8% -5.0%
DPS n/a -36.1%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 4,560.00 246.00 64.60¢ 30.1 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 20.6 0.8 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 17.5 17.5 +1% 37.50¢ 2.6%
31-Dec-23 5,549.00 290.00 82.80¢ 16.8 16.8 +1% 37.50¢ 2.7%
31-Dec-24 5,810.00 498.00 84.30¢ 15.2 7.6 +2% 37.50¢ 2.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 6,063.89 1,044.45 80.06p 12.9 n/a -5% 30.89p 0.0%
31-Dec-26 6,366.36 1,164.28 90.69p 11.4 0.9 +13% 34.04p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Total Voting Rights 01-Apr-2025 12:41 RNS
Director/PDMR Shareholding 27-Mar-2025 09:17 RNS
Director/PDMR Shareholding 27-Mar-2025 09:12 RNS

Smith and Nephew ShareCast News

Smith & Nephew shares lift as profits, sales bea... 25-Feb-2025 ShareCast
Berenberg lowers Smtih and Nephew to 'hold' 06-Nov-2024 ShareCast
London close: Stocks mixed on eve of US presiden... 04-Nov-2024 ShareCast

Smith and Nephew Top Newspaper Links

Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph
MARKET REPORT: Bid talk boosts Smith & Nephew 26-Nov-2014 Express & Star

Latest Smith and Nephew Director Deals

Traded Action Notifier PriceAmountValue
26-Mar-25 Buy Sybella Stanley 1,101.00p 3,810 £41,948.10

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,030.50p
Change Today -47.00p
% Change -4.36 %
52 Week High 1,208.50
52 Week Low 917.60
Volume 3,458,286
Shares Issued 875.93m
Market Cap £9,026m
Beta 0.02
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.08% below the market average76.08% below the market average76.08% below the market average76.08% below the market average76.08% below the market average
69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average
Price Trend
21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average
Income
10% below the market average10% below the market average10% below the market average10% below the market average10% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
4.01% below the market average4.01% below the market average4.01% below the market average4.01% below the market average4.01% below the market average
82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average82.35% below the sector average

What The Brokers Say

Strong Buy 4
Buy 4
Neutral 10
Sell 0
Strong Sell 0
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Final Interim
Ex-Div 27-Mar-25 03-Oct-24
Paid 28-May-25 08-Nov-24
Amount 23.10¢ 14.40¢

Trades for 04-Apr-2025

Time Volume / Share Price
14:41 4 @ 1,034.00p
16:35 55 @ 1,030.50p
16:35 2,743 @ 1,030.50p
16:35 21,385 @ 1,030.50p
16:35 23,805 @ 1,030.50p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page